Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable clinical outcomes. Despite advances in treatment, predicting disease progression and identifying high-risk patients remains a major clinical challenge.

A new study published in Microbiome Research Reports reports that the gut microbiome of IBD patients can be grouped into distinct compositional “cluster types” associated with disease severity and progression risk. These clusters reflect higher-order microbial community organization rather than variation in individual bacterial species.

The findings suggest that the gut microbiome functions as an interconnected ecological network, where disease-relevant signals emerge from community-level structure rather than single taxa. Importantly, the identified clusters were independent of conventional diagnostic categories, including Crohn’s disease and ulcerative colitis, indicating that microbiome-based stratification may capture biologically meaningful variation not reflected in current clinical classification systems.

According to the authors, this network-based perspective provides a more integrated view of host–microbe interactions in IBD and may help explain variability in disease progression among patients with similar diagnoses. While further validation in larger cohorts is required, the results suggest that community-level microbiome patterns could contribute to improved patient stratification and more personalized IBD management.

The work titled “Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories”, was published on Microbiome Research Reports (published on March 18, 2026).
DOI：10.20517/mrr.2025.96